Armistice Capital, LLC Clearside Biomedical, Inc. Call Options Transaction History
Armistice Capital, LLC
- $7.69 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CLSD
# of Institutions
53Shares Held
13.4MCall Options Held
17.6KPut Options Held
100-
Vanguard Group Inc Valley Forge, PA2.84MShares$3.29 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$2.55 Million3.43% of portfolio
-
Carmignac Gestion Paris, I02.13MShares$2.47 Million0.05% of portfolio
-
Black Rock Inc. New York, NY798KShares$925,8380.0% of portfolio
-
Geode Capital Management, LLC Boston, MA672KShares$779,8640.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $69.8M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...